Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va.

0
15

Teva Pharmaceutical Industries Ltd. TEVA, +2.31% said Wednesday it agreed to make $110 million in payments to settle opioid claims against it by West Virginia. The company will pay $75 million over 15 years plus $8 million for legal fees. It will also provide $27 million worth of the generic version of Narcan over 10 years. Teva said the settlement is “consistent with previously announced settlement as it continues to negotiate a national settlement. Teva did not admit any liability or wrongdoing as part of the deal. Shares of Teva rose 2.2% on Wednesday morning. The stock is up 7.8% so far this year, compared to a loss of 17.2% by the S&P 500 SPX, +0.13%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: CEO who wants his company to be the Toyota of rocket launchers says losing two-thirds of its value won’t change strategy
Next articleBernanke: Why the Fed didn’t act faster to rein in inflation

LEAVE A REPLY

Please enter your comment!
Please enter your name here